HLB Life Science Co. Ltd (067630) — Cash Flow Quality Index
HLB Life Science Co. Ltd (067630) has a Cash Flow Quality Index of -5.16x as of December 2024. Operating cash flow of ₩-32.01 Billion is below net income of ₩6.21 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore HLB Life Science Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HLB Life Science Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for HLB Life Science Co. Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 067630 cash flow metrics.
Annual Cash Flow Quality Index for HLB Life Science Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for HLB Life Science Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -5.16x | ₩-32.01 Billion | ₩6.21 Billion | ▼ -13149.7% |
| 2017 | -0.04x | ₩-302.04 Million | ₩7.76 Billion | ▼ -100.5% |
| 2014 | 7.43x | ₩10.43 Billion | ₩1.40 Billion | — |